Impact of Proton Pump Inhibitors

The Impact of Proton Pump Inhibitors on Cardiovascular Related Event Costs in Patients Initiating Clopidogrel

Authors: RE Aubert, EJ Stanek, J Yao, FW Frueh, JR Teagarden, RS Epstein

Combined clopidogrel and PPI therapy signifiantly increased the risk of major cardiovascular events and associated costs over 12-months following PCI/stent placement.

Citation: Value in Health, Volume 12, Issue 3, May 2009, Page A7

Link: http://www.sciencedirect.com/science/article/pii/S1098301510730977?_alid=1838934470&_rdoc=2&_fmt=high&_origin=search&_docanchor=&_ct=11&_zone=rslt_list_item&md5=1b32ebc6385fd502d78e876bf46f7857